<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2219">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 19, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01445730</url>
  </required_header>
  <id_info>
    <org_study_id>T1010K0029</org_study_id>
    <nct_id>NCT01445730</nct_id>
  </id_info>
  <brief_title>Fructose Consumption and Metabolic Dysregulation</brief_title>
  <official_title>Fructose Consumption Aggravates Dysregulation of Postprandial Lipid Metabolism in Obese Hypertriglyceridemic Men With High Cardiometabolic Risk Profile and Associates With Liver Fat Deposition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Marja-Riitta Taskinen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lund University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Naples</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      High fructose intake is increasingly recognized as causative in development of prediabetes,&#xD;
      metabolic syndrome and cardiovascular disease (CVD). The mechanisms underlying&#xD;
      fructose-induced metabolic disturbances are unclear but are beginning to be unraveled. In&#xD;
      contrast to metabolism of glucose, the breakdown of fructose leads to the generation of&#xD;
      metabolites that stimulate hepatic de novo lipogenesis (DNL) and increased levels of both&#xD;
      fasting and postprandial triglycerides. The key lipogenic transcription factor seems to be&#xD;
      activated by fructose independently of insulin. However, it is still controversial whether&#xD;
      fructose consumption increases DNL in man to the extent that it induces metabolic&#xD;
      disturbances. Animal studies have shown that also the adipose tissue is responsive to&#xD;
      fructose feeding fructose, and that high fructose-feeding induces insulin resistance and&#xD;
      inflammation in the adipose tissue. The role of intestinal insulin resistance in&#xD;
      fructose-induced dysmetabolism has not been studied in detail. The critical question is&#xD;
      whether the metabolic disturbances are induced by calorie excess or by fructose per se.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Detailed description: Study subjects will participate to studies 1-4 before and 3 m after&#xD;
      fructose diet:&#xD;
&#xD;
        1. An oral fat load or a kinetic study with stable isotopes combined with an oral fat load.&#xD;
&#xD;
        2. Determination of liver, subcutaneous and intra-abdominal fat. (Proton magnetic resonance&#xD;
           spectroscopy )&#xD;
&#xD;
        3. Lipolytic enzymes, advanced lipid analysis, fat biopsies and genetic studies and gut&#xD;
           microbiota profiling&#xD;
&#xD;
        4. Oral glucose tolerance test and analysis of incretins and inflammatory biomarkers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>TG Plasma AUC</measure>
    <time_frame>Form the baseline (time point 1) to end of treatment at 3 months (time point 2)</time_frame>
    <description>Before vs. after fructose challenge: Triglycerides (TG) plasma Area Under Curve (AUC)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>B48 Plasma AUC</measure>
    <time_frame>Form the baseline (time point 1) to end of treatment at 3 months (time point 2)</time_frame>
    <description>Before vs. after fructose challenge: apolipoprotein (apo)B48 plasma Area Under Curve (AUC)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TG Plasma iAUC</measure>
    <time_frame>Form the baseline (time point 1) to end of treatment at 3 months (time point 2)</time_frame>
    <description>Before vs. after fructose challenge:Triglycerides (TG) plasma incremental Area Under Curve (iAUC)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>DNL</measure>
    <time_frame>Form the baseline (time point 1) to end of treatment at 3 months (time point 2)</time_frame>
    <description>Before vs. after fructose challenge: de novo lipogenesis (DNL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ApoC-III</measure>
    <time_frame>Form the baseline (time point 1) to end of treatment at 3 months (time point 2)</time_frame>
    <description>Before vs. after fructose challenge: Apolipoprotein C-III (ApoC-III)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>β-OH Butyrate</measure>
    <time_frame>Form the baseline (time point 1) to end of treatment at 3 months (time point 2)</time_frame>
    <description>Before vs. after fructose challenge: beta-OH butyrate (β-OH butyrate)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver Fat</measure>
    <time_frame>Form the baseline (time point 1) to end of treatment at 3 months (time point 2)</time_frame>
    <description>Before vs. after fructose challenge</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">82</enrollment>
  <condition>Central Obesity</condition>
  <condition>Hypertriglyceridemia</condition>
  <arm_group>
    <arm_group_label>After fructose feeding</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After 3 month fructose diet 75 g/day</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fructose</intervention_name>
    <description>3 month fructose diet 75 g/day</description>
    <arm_group_label>After fructose feeding</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Body mass index 27-40&#xD;
&#xD;
          -  Waist &gt; 96 cm&#xD;
&#xD;
          -  Age 20-60 years&#xD;
&#xD;
          -  Male&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Active health problems&#xD;
&#xD;
          -  Contraindications to MRI scanning&#xD;
&#xD;
          -  Bleeding tendency&#xD;
&#xD;
          -  Abnormal liver or renal function tests&#xD;
&#xD;
          -  Type 2 diabetes&#xD;
&#xD;
          -  Evidence of metabolic or viral liver disease&#xD;
&#xD;
          -  Alcohol intake &gt; 21 units per week&#xD;
&#xD;
          -  Chronic medication except ones needed for stable hypertension&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marja-Riitta Taskinen, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki University Central Hospital, Biomedicum</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Université Laval</name>
      <address>
        <city>Québec</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helsinki University Central Hospital, Biomedicum</name>
      <address>
        <city>Helsinki</city>
        <zip>00290</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Naples, Federico II, and Faculty of Medicine</name>
      <address>
        <city>Naples</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska Academy at University of Gothenburg and Sahlgrenska University Hospital</name>
      <address>
        <city>Gothenburg</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Finland</country>
    <country>Italy</country>
    <country>Sweden</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>September 28, 2011</study_first_submitted>
  <study_first_submitted_qc>September 30, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 4, 2011</study_first_posted>
  <results_first_submitted>April 22, 2021</results_first_submitted>
  <results_first_submitted_qc>May 19, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">June 15, 2021</results_first_posted>
  <last_update_submitted>May 19, 2021</last_update_submitted>
  <last_update_submitted_qc>May 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Marja-Riitta Taskinen</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>fructose</keyword>
  <keyword>hypertriglyceridemia</keyword>
  <keyword>postprandial lipids</keyword>
  <keyword>de novo lipogenesis</keyword>
  <keyword>stable isotopes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertriglyceridemia</mesh_term>
    <mesh_term>Obesity, Abdominal</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>August 26, 2013</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/30/NCT01445730/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>After Fructose Feeding</title>
          <description>After 3 month fructose diet 75 g/day</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="82"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="71"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>For the advice of a dentist</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>The data from magnetic resonance examinations were not sufficient</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Of the 82 subjects, two subjects discontinued the intervention study: one developed a skin rash, which was considered as possible allergic reaction to flavouring and the other subject discontinued in response to his dentist's advice. In addition, the data from magnetic resonance examinations at baseline or after the fructose intervention were not sufficient from nine subjects for technical reasons to allow the analyses of different fat depots. Thus, 71 subjects completed the full study protocol.</population>
      <group_list>
        <group group_id="B1">
          <title>After Fructose Feeding</title>
          <description>After 3 month fructose diet 75 g/day</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="82"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="82"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="82"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="82"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="82"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sweden</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="82"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Finland</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="82"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Italy</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="82"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>TG Plasma AUC</title>
        <description>Before vs. after fructose challenge: Triglycerides (TG) plasma Area Under Curve (AUC)</description>
        <time_frame>Form the baseline (time point 1) to end of treatment at 3 months (time point 2)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>After Fructose Feeding</title>
            <description>After 3 month fructose diet 75 g/day</description>
          </group>
        </group_list>
        <measure>
          <title>TG Plasma AUC</title>
          <description>Before vs. after fructose challenge: Triglycerides (TG) plasma Area Under Curve (AUC)</description>
          <units>mmol/l*min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="71"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Time point 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1130" spread="590"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Time point 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1220" spread="598"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.005</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>B48 Plasma AUC</title>
        <description>Before vs. after fructose challenge: apolipoprotein (apo)B48 plasma Area Under Curve (AUC)</description>
        <time_frame>Form the baseline (time point 1) to end of treatment at 3 months (time point 2)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>After Fructose Feeding</title>
            <description>After 3 month fructose diet 75 g/day</description>
          </group>
        </group_list>
        <measure>
          <title>B48 Plasma AUC</title>
          <description>Before vs. after fructose challenge: apolipoprotein (apo)B48 plasma Area Under Curve (AUC)</description>
          <units>mg/l*min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="71"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Time point 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7660" spread="3210"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Time point 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8200" spread="3340"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.04</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>TG Plasma iAUC</title>
        <description>Before vs. after fructose challenge:Triglycerides (TG) plasma incremental Area Under Curve (iAUC)</description>
        <time_frame>Form the baseline (time point 1) to end of treatment at 3 months (time point 2)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>After Fructose Feeding</title>
            <description>After 3 month fructose diet 75 g/day</description>
          </group>
        </group_list>
        <measure>
          <title>TG Plasma iAUC</title>
          <description>Before vs. after fructose challenge:Triglycerides (TG) plasma incremental Area Under Curve (iAUC)</description>
          <units>mmol/l*min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="71"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Time point 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="377" spread="422"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Time point 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="422" spread="270"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.04</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>DNL</title>
        <description>Before vs. after fructose challenge: de novo lipogenesis (DNL)</description>
        <time_frame>Form the baseline (time point 1) to end of treatment at 3 months (time point 2)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>After Fructose Feeding</title>
            <description>After 3 month fructose diet 75 g/day</description>
          </group>
        </group_list>
        <measure>
          <title>DNL</title>
          <description>Before vs. after fructose challenge: de novo lipogenesis (DNL)</description>
          <units>μmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="71"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Time point 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.3" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Time point 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.5" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.005</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ApoC-III</title>
        <description>Before vs. after fructose challenge: Apolipoprotein C-III (ApoC-III)</description>
        <time_frame>Form the baseline (time point 1) to end of treatment at 3 months (time point 2)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>After Fructose Feeding</title>
            <description>After 3 month fructose diet 75 g/day</description>
          </group>
        </group_list>
        <measure>
          <title>ApoC-III</title>
          <description>Before vs. after fructose challenge: Apolipoprotein C-III (ApoC-III)</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="71"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Time point 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.4" spread="5.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Time point 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.2" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.006</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>β-OH Butyrate</title>
        <description>Before vs. after fructose challenge: beta-OH butyrate (β-OH butyrate)</description>
        <time_frame>Form the baseline (time point 1) to end of treatment at 3 months (time point 2)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>After Fructose Feeding</title>
            <description>After 3 month fructose diet 75 g/day</description>
          </group>
        </group_list>
        <measure>
          <title>β-OH Butyrate</title>
          <description>Before vs. after fructose challenge: beta-OH butyrate (β-OH butyrate)</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="71"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Time point 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.699" spread="0.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Time point 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.542" spread="0.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.01</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Liver Fat</title>
        <description>Before vs. after fructose challenge</description>
        <time_frame>Form the baseline (time point 1) to end of treatment at 3 months (time point 2)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>After Fructose Feeding</title>
            <description>After 3 month fructose diet 75 g/day</description>
          </group>
        </group_list>
        <measure>
          <title>Liver Fat</title>
          <description>Before vs. after fructose challenge</description>
          <units>percentage of liver fat content</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="71"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Time point 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.66" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Time point 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.33" spread="6.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.008</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>During 3 month fructose diet 75 g/day.</time_frame>
      <desc>Of the 82 subjects, two subjects discontinued the intervention study: one developed a skin rash, which was considered as possible allergic reaction to flavouring and the other subject discontinued in response to his dentist's advice. In addition, the data from magnetic resonance examinations at baseline or after the fructose intervention were not sufficient from nine subjects for technical reasons to allow the analyses of different fat depots. Thus, 71 subjects completed the full study protocol.</desc>
      <group_list>
        <group group_id="E1">
          <title>After Fructose Feeding</title>
          <description>After 3 month fructose diet 75 g/day</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="82"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="82"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0.01</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="82"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>skin rash</sub_title>
                <description>One subject developed a skin rash which was considered as possible allergic reaction to flavouring. The rash disappeared after the discontinuation.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="82"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof. Marja-Riitta Taskinen</name_or_title>
      <organization>Helsinki University and Helsinki University Hospital</organization>
      <phone>+358-9-4717 1990</phone>
      <email>marja-riitta.taskinen@helsinki.fi</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

